Edesa Biotech Inc (EDSA)
4.632
+0.08
(+1.70%)
USD |
NASDAQ |
May 03, 16:00
4.53
-0.10
(-2.21%)
After-Hours: 20:00
Edesa Biotech Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.3288M |
| June 30, 2020 | 0.7387M |
| March 31, 2020 | 0.6292M |
| December 31, 2019 | 0.6364M |
| September 30, 2019 | 0.5817M |
| June 30, 2019 | 0.2255M |
| March 31, 2019 | 0.2981M |
| December 31, 2018 | 0.2444M |
| September 30, 2018 | 0.2118M |
| June 30, 2018 | 0.1605M |
| March 31, 2018 | 0.108M |
| December 31, 2017 | 0.1069M |
| September 30, 2017 | 0.2283M |
| June 30, 2017 | 0.5015M |
| March 31, 2017 | 0.6621M |
| December 31, 2016 | 0.9254M |
| September 30, 2016 | 1.272M |
| June 30, 2016 | 1.196M |
| March 31, 2016 | 1.173M |
| December 31, 2015 | 1.034M |
| Date | Value |
|---|---|
| September 30, 2015 | 0.7587M |
| June 30, 2015 | 0.6773M |
| March 31, 2015 | 0.6222M |
| December 31, 2014 | 0.5256M |
| August 31, 2014 | 0.3721M |
| May 31, 2014 | 0.5479M |
| February 28, 2014 | 0.5185M |
| November 30, 2013 | 0.4889M |
| August 31, 2013 | 0.5455M |
| May 31, 2013 | 0.2997M |
| February 28, 2013 | 0.2697M |
| November 30, 2012 | 0.2664M |
| August 31, 2012 | 0.2861M |
| May 31, 2012 | 0.2771M |
| February 29, 2012 | 0.2755M |
| November 30, 2011 | 0.7627M |
| August 31, 2011 | 0.6972M |
| May 31, 2011 | 1.202M |
| February 28, 2011 | 1.322M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.2255M
Minimum
Jun 2019
0.7387M
Maximum
Jun 2020
0.5234M
Average
0.6055M
Median
Revenue (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Lexaria Bioscience Corp | 0.386M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |